NCT06637527Phase 2Terminated

The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain

Study sponsor: Okyo Pharma Ltd · OKYO

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-04-30Actual
Enrollment · participants18Actual
Source updated2025-08-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview